Wow! eBook
Primary Central Nervous System Tumors: Pathogenesis and Therapy 2011th Edition
Author(s): Andrew D. Norden (Editor), David A. Reardon (Editor), Patrick C. Y. Wen (Editor)
- Publisher: Humana
- Publication Date: 28 Jan. 2013
- Edition: 2011th
- Language: English
- Print length: 584 pages
- ISBN-10: 1617797235
- ISBN-13: 9781617797231
Book Description
This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.
Editorial Reviews
Review
From the reviews:
“In this compendium of current literature on brain tumors and treatment paradigms, the chapters are well written by experts in the field who present the information in a concise and clinically applicable format. … It is written for clinicians involved in the care of patients with brain tumors. … which is to provide a readable and thorough resource on CNS tumors for practicing physicians.” (Mark K. Lyons, Doody’s Review Service, February, 2011)
From the Back Cover
This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.
